These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 17893973

  • 1. Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.
    Kiss E, Seres I, Tarr T, Kocsis Z, Szegedi G, Paragh G.
    Ann N Y Acad Sci; 2007 Jun; 1108():83-91. PubMed ID: 17893973
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of paraoxonase activity and lipid profile in lupus patients].
    Kiss E, Seres I, Zsolt K, Tarr T, Csípo I, Szegedi G, Paragh G.
    Orv Hetil; 2005 Nov 20; 146(47):2395-402. PubMed ID: 16398152
    [Abstract] [Full Text] [Related]

  • 3. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K, Tarr T, Lőrincz H, Borbás V, Seres I, Harangi M, Fülöp P, Paragh G.
    Lipids Health Dis; 2016 Mar 22; 15():60. PubMed ID: 27004558
    [Abstract] [Full Text] [Related]

  • 4. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
    Tanhapour M, Miri A, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, Pourmotabbed T, Shakiba E.
    Clin Rheumatol; 2018 Apr 22; 37(4):971-977. PubMed ID: 29273831
    [Abstract] [Full Text] [Related]

  • 5. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F, Vaisi-Raygani A, Rahimi Z, Ahmadi R, Kiani A, Tavilani H, Vaisi-Raygani H, Pourmotabbed T.
    Lupus; 2014 Mar 22; 23(3):263-72. PubMed ID: 24399815
    [Abstract] [Full Text] [Related]

  • 6. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY, Gümüşlü S, Semiz E.
    Clin Cardiol; 2004 Jul 22; 27(7):426-30. PubMed ID: 15298047
    [Abstract] [Full Text] [Related]

  • 7. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, Nomani H, Ebrahimi A, Tavilani H, Pourmotabbed T.
    Br J Dermatol; 2012 Dec 22; 167(6):1279-86. PubMed ID: 22835076
    [Abstract] [Full Text] [Related]

  • 8. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P, Rodríguez-Carrio J, Martínez-Zapico A, Pérez-Álvarez ÁI, López-Mejías R, Benavente L, Mozo L, Caminal-Montero L, González-Gay MA, Suárez A.
    Thromb Haemost; 2017 Nov 22; 117(11):2194-2206. PubMed ID: 29044294
    [Abstract] [Full Text] [Related]

  • 9. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z.
    Acta Biochim Pol; 2006 Nov 22; 53(4):783-7. PubMed ID: 17106515
    [Abstract] [Full Text] [Related]

  • 10. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
    Aslan M, Horoz M, Sabuncu T, Celik H, Selek S.
    Pol Arch Med Wewn; 2011 Jun 22; 121(6):181-6. PubMed ID: 21694681
    [Abstract] [Full Text] [Related]

  • 11. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A, Jurkovicova I, Fabryova L, Kinova S, Koren M, Stecova A, Svitekova K.
    Diabetes Res Clin Pract; 2018 Jun 22; 140():174-182. PubMed ID: 29626583
    [Abstract] [Full Text] [Related]

  • 12. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A.
    Clin Chim Acta; 2014 Feb 15; 429():38-45. PubMed ID: 24280342
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice.
    Srivastava R, Yu S, Parks BW, Black LL, Kabarowski JH.
    Arthritis Rheum; 2011 Jan 15; 63(1):201-11. PubMed ID: 20882670
    [Abstract] [Full Text] [Related]

  • 14. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T, Martin-Nizard F, Kandoussi A, Kyndt X, Vanhille P, Hachulla E, Hatron PY, Fruchart JC, Duriez P, Lambert M.
    Semin Arthritis Rheum; 2007 Dec 15; 37(3):149-55. PubMed ID: 17512573
    [Abstract] [Full Text] [Related]

  • 15. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM, Manzi S, Chen Q, Kenney M, Shaw P, Kao A, Bontempo F, Kammerer C, Kamboh MI.
    Arthritis Rheum; 2006 Jun 15; 54(6):1928-39. PubMed ID: 16729301
    [Abstract] [Full Text] [Related]

  • 16. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB, Giles IP, Rahman A.
    Lupus; 2011 Jan 15; 20(1):5-13. PubMed ID: 21138982
    [Abstract] [Full Text] [Related]

  • 17. Activity of paraoxonase 1 and lipid profile in healthy children.
    Sumegová K, Nagyová Z, Waczulíková I, Zitnanová I, Duracková Z.
    Physiol Res; 2007 Jan 15; 56(3):351-357. PubMed ID: 16792468
    [Abstract] [Full Text] [Related]

  • 18. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, Gill KD.
    Gene; 2011 Nov 01; 487(1):88-95. PubMed ID: 21803130
    [Abstract] [Full Text] [Related]

  • 19. [Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers].
    Haj Mouhamed D, Ezzaher A, Araoud M, Neffati F, Douki W, Najjar MF.
    Ann Biol Clin (Paris); 2010 Nov 01; 68(2):143-7. PubMed ID: 20348046
    [Abstract] [Full Text] [Related]

  • 20. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
    Viktorinova A, Svitekova K, Stecova A, Krizko M.
    Clin Biochem; 2016 Aug 01; 49(12):868-72. PubMed ID: 27240017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.